首頁 > 市場調查報告書 > 製藥

循環系統

市場調查報告書

商品編碼

2075818

Sildenafil藥物市場：依藥物類型、適應症、通路、劑型及地區分類。

Sildenafil Drug Market, By Drug Type, By Indication, By Distribution Channel, By Dosage Form, By Geography

出版日期: 2026年04月29日 | 出版商:

Coherent Market Insights | 英文 250+ Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

據估計，Sildenafil藥物市場在2026年將達到35.3億美元，預計2033年將達到56.3億美元。預計從2026年到2033年，其複合年成長率將達到6.9%。

報告範圍		報告詳情
基準年：	2025	2026年市場規模：	35.3億美元
歷史數據時期：	2020年至2024年	預測期：	2026年至2033年
2026年至2033年預測期間的複合年成長率：	6.90%	2033年市場規模預測：	56.3億美元

Sildenafil，俗稱“小藍丸”，是一種主要用於治療勃起功能障礙（ED）的藥物。它屬於磷酸二酯酶5型（PDE5）抑制劑類藥物，以「威而鋼」（Viagra）的品牌名銷售。Sildenafil的作用機轉是放鬆陰莖血管中的平滑肌，從而增加血流量，最終促進勃起。

自90年代末期問世以來，Sildenafil徹底改變了勃起功能障礙（ED）的治療領域，為全球數百萬男性帶來了福音。對於那些難以勃起或維持勃起的男性來說，Sildenafil已成為一種值得信賴的藥物，它提供了一種有效的解決方案，改變了許多人的生活。

市場動態：

預計Sildenafil市場在預測期內將出現顯著成長。推動這一成長的主要因素包括全球勃起功能障礙盛行率的上升、人口老化以及人們對性健康意識的增強。

然而，市場也面臨許多挑戰。其中一個主要限制因素是市場上仿冒品的Sildenafil，這可能對消費者構成嚴重的健康風險。監管機構和製藥公司正在努力打擊假藥。

儘管面臨這些挑戰，Sildenafil市場仍蘊藏著許多機會。創新劑型的研發，例如口溶錠和咀嚼片，將為病人帶來用藥的便利。此外，Sildenafil學名藥的出現有望透過降低藥物價格和提高可及性來推動市場成長。

本研究的主要特點：

本研究探討了各個細分市場的潛在商機，並為該市場提出了有吸引力的投資提案。
本研究深入分析了市場促進因素、限制因素、機會、新產品發布和批准、市場趨勢、區域展望以及主要參與者採取的競爭策略。
本報告介紹了全球Sildenafil製藥市場主要參與者的概況，重點介紹了他們的背景、產品系列、主要成就、財務表現和策略。
本次調查涵蓋了輝瑞、梯瓦製藥、奧羅賓多製藥、阿萊姆比克製藥、特倫特製藥、魯賓、瑞迪博士實驗室、齊杜斯卡迪拉、安尼爾製藥、海特羅、阿波泰克斯、邁蘭、阿旃陀製藥、太陽製藥、西普拉、諾華、禮來、賽諾菲、拜耳和GlaxoSmithKline Plc等領先公司。
本報告提供的見解將使行銷負責人和經營團隊能夠就產品發布、升級、市場擴張和行銷策略做出明智的決策。
該行業的各個相關人員，包括投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師，都可以從本報告的研究結果中受益。
相關人員可以利用Sildenafil藥物市場分析中使用的策略矩陣來簡化決策流程。

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 英國
- 法國
- 義大利
- 西班牙
- 俄羅斯
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- 澳洲
- 韓國
- ASEAN
- 其他亞太國家
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 其他拉丁美洲國家
中東
- 海灣合作理事會國家
- 以色列
- 其他中東國家
非洲
- 南非
- 中非
- 北非

第9章競爭情勢

公司簡介
- Pfizer
- Teva Pharmaceuticals
- Aurobindo Pharma
- Alembic Pharmaceuticals
- Torrent Pharmaceuticals
- Lupin
- Reddy's Laboratories
- Zydus Cadila
- Amneal Pharmaceuticals
- Hetero
- Apotex
- Mylan
- Ajanta Pharma
- Sun Pharmaceutical
- Cipla
- Novartis
- Eli Lily
- Sanofi
- Bayer
- GlaxoSmithKline
分析師意見

第10章

參考
調查方法
關於本公司

簡介目錄

Product Code: CMI6336

Sildenafil Drug Market is estimated to be valued at USD 3.53 Bn in 2026 and is expected to reach USD 5.63 Bn by 2033, growing at a compound annual growth rate (CAGR) of 6.9% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 3.53 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	6.90%	2033 Value Projection:	USD 5.63 Bn

Sildenafil which is commonly known as the little blue pill, is a widely used drug primarily used to treat erectile dysfunction (ED). It belongs to the class of medications called phosphodiesterase type 5 (PDE5) inhibitors and is marketed under the brand name Viagra. Sildenafil works by relaxing the smooth muscles of the blood vessels in the penis, thereby allowing for increased blood flow and ultimately facilitating an erection.

Since its introduction in the late 1990s, sildenafil has revolutionized the field of ED treatment, providing relief to millions of men worldwide. It has become the go-to medication for individuals experiencing difficulties in achieving and maintaining an erection, thereby offering an effective solution that has transformed the lives of many.

Market Dynamics:

The sildenafil drug market is expected to witness significant growth in the forecast period. The key drivers for this growth include the increasing prevalence of erectile dysfunction worldwide, the growing aging population, and the rising awareness regarding sexual health.

However, the market has also challenges. The significant restraint is the presence of counterfeit sildenafil products in the market, which can pose serious health risks to consumers. Regulatory bodies and pharmaceutical companies are making efforts to crack down on counterfeit drugs.

Despite these challenges, the sildenafil market presents several opportunities. The development of innovative dosage forms, such as orally disintegrating tablets and chewable tablets, offers convenience and ease of administration for patients. The emergence of generic versions of sildenafil is expected to drive the market growth by making the drug more affordable and accessible.

Key Features of the Study:

The study explores potential revenue opportunities across different market segments and presents attractive investment propositions for this market
It offers key insights into market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
The report profiles key players in the global sildenafil drug market, highlighting their company background, product portfolio, key accomplishments, financial performance, and strategies
The study includes key companies such as Pfizer, Teva Pharmaceuticals, Aurobindo Pharma, Alembic Pharmaceuticals, Torrent Pharmaceuticals, Lupin, Dr Reddy's Laboratories, Zydus Cadila, Amneal Pharmaceuticals, Hetero, Apotex, Mylan, Ajanta Pharma, Sun Pharmaceutical, Cipla, Novartis, Eli Lily, Sanofi, Bayer, and GlaxoSmithKline.
The insights provided by this report would enable marketers and management authorities to make informed decisions regarding product launches, upgrades, market expansion, and marketing tactics
Various stakeholders in this industry, including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts, would benefit from the findings of this report
Stakeholders can leverage the strategy matrices used in analyzing the sildenafil drug market to facilitate decision-making processes

Detailed Segmentation:

Sildenafil Drug Market, By Drug Type (Revenue, USD Bn, 2021 - 2033)
Branded Drugs
Generic Drugs
Over The Counter Drugs
Sildenafil Drug Market, By Indication (Revenue, USD Bn, 2021 - 2033)
Erectile Dysfunction
Pulmonary Arterial Hypertension
Benign Prostatic Hyperplasia
Others (Premature Ejaculation, Altitude Sickness)
Sildenafil Drug Market, By Distribution Channel (Revenue, USD Bn, 2021 - 2033)
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Others (Clinics, Mail Order Pharmacies)
Sildenafil Drug Market, By Dosage Form (Revenue, USD Bn, 2021 - 2033)
Tablets
Oral Jellies
Injections
Others (Suspensions, Capsules)
Regional Insights (Revenue, USD Bn, 2021 - 2033)
North America
- U.S.
- Canada
Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
Middle East
- GCC Countries
- Israel
- Rest of Middle East
Africa
- South Africa
- North Africa
- Central Africa
Top Companies in Sildenafil Drug Market:
Pfizer
Teva Pharmaceuticals
Aurobindo Pharma
Alembic Pharmaceuticals
Torrent Pharmaceuticals
Lupin
Reddy's Laboratories
Zydus Cadila
Amneal Pharmaceuticals
Hetero
Apotex
Mylan
Ajanta Pharma
Sun Pharmaceutical
Cipla
Novartis
Eli Lily
Sanofi
Bayer
GlaxoSmithKline

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By Drug Type
- Market Snippet, By Indication
- Market Snippet, By Distribution Channel
- Market Snippet, By Dosage Form
- Market Snippet, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
  - Increasing prevalence of erectile dysfunction
- Restraints
  - Adverse effects and safety concerns
- Opportunities
  - Development of novel drug delivery system
Key Highlights
Regulatory Scenario
Recent Trends
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Mergers, Acquisitions, ad Collaborations

4. Sildenafil Drug Market, By Drug Type, 2021-2033, (US$ Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Branded Drugs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
Generic Drugs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
Over The Counter Drugs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)

5. Sildenafil Drug Market, By Indication, 2021 - 2033, (US$ Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Erectile Dysfunction
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
Pulmonary Arterial Hypertension
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
Benign Prostatic Hyperplasia
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
Others (Premature Ejaculation, Altitude Sickness)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)

6. Sildenafil Drug Market, By Distribution Channel, 2021 - 2033, (US$ Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
Others (Clinics, Mail Order Pharmacies)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)

7. Sildenafil Drug Market, By Dosage Form, 2021 - 2033, (US$ Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Tablets
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
Oral Jellies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
Injections
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
Others (Suspensions, Capsules)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)

8. Sildenafil Drug Market, By Region, 2021 - 2033, (US$ Bn)

Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Region, 2022 -2033
- Country Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
  - U.S.
  - Canada
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
  - Germany
  - U.K.
  - France
  - Italy
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 - 2033,(US$ Bn)
  - South Africa
  - Central Africa
  - North Africa

9. Competitive Landscape

Company Profile
- Pfizer
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Teva Pharmaceuticals
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Aurobindo Pharma
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Alembic Pharmaceuticals
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Torrent Pharmaceuticals
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Lupin
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Reddy's Laboratories
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Zydus Cadila
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Amneal Pharmaceuticals
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Hetero
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Apotex
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Mylan
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Ajanta Pharma
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Sun Pharmaceutical
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Cipla
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Novartis
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Eli Lily
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Sanofi
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Bayer
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- GlaxoSmithKline
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
Analyst Views